Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | APN401 |
Trade Name | |
Synonyms | |
Drug Descriptions |
APN401 is composed of autologous peripheral blood mononuclear cells in which Cbl-b has been silenced with siRNA, which potentially results in increased anti-tumor immune response upon infusion (J Clin Oncol 34, 2016 (suppl; abstr e14541)). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C116353 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
APN401 | APN401 | 0 | 2 |